NYSE:AEON | Free Cash Flow | AEON Biopharma, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2021-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$2.64M
2025-12-31-$4.71M$0.00-$4.71M
2025-03-31-$7.91M$4,000.00-$7.91M-87.00%
2024-12-31-$621,000.00
2024-03-31-$8.6M
2023-09-30-$15.06M
2023-03-31-$11.06M
2022-12-31-$8.45M$9,000.00-$8.46M
2022-03-31-$411,669.00
2021-12-31-$162,633.00
2021-03-31-$554,518.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$17.31M$4,000.00-$17.31M
2024-12-31-$20.29M
2022-12-31-$35.58M$306,000.00-$35.89M
2021-12-31-$1.49M